Navigation Links
Alexza Pharmaceuticals Files Shelf Registration Statement
Date:5/4/2010

MOUNTAIN VIEW, Calif., May 4 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has filed a universal shelf registration statement with the Securities and Exchange Commission (SEC) that, if declared effective by the SEC, will allow the Company to sell, from time to time, up to $75 million of its common stock, preferred stock, debt securities and/or warrants, either individually or in units, in one or more offerings.  As of the date of this release, the Company has no specific plans to offer the securities covered by the registration statement and the Company is not required to offer the securities in the future pursuant to the registration statement.  The terms of any offering under the registration statement will be established at the time of the offering.  Proceeds from the sale of any securities will be used for the purposes described in a prospectus supplement filed at the time of an offering.  The universal shelf registration statement is intended to provide Alexza Pharmaceuticals with flexibility to raise funds from the offering of its securities in one or more offerings, subject to market conditions and the Company's capital needs.

A shelf registration statement relating to these securities was filed today with the SEC but has not yet become effective.  The securities offered by the Company pursuant to the registration statement may not be sold, nor may offers to buy the securities be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities in any jurisdiction in which such offer, solicit
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... -- Thousands of people will peacefully demonstrate their frustration ... epidemic at dozens of rallies across the country today. ... the United States has experienced skyrocketing rates ... heroin, yet the President has never once spoken publicly ... to President Obama , rally organizers compared his failure ...
(Date:8/31/2015)... 2015 With increasing clinical applications, the ... rise in active partnerships. The primary reason for ... quantitate CD4 cell markers in human immunodeficiency virus ... New analysis from Frost ... Market ( http://www.frost.com/nf0e ), finds the market earned ...
(Date:8/31/2015)... Aug. 31, 2015 The Wolf Administration today ... Pennsylvania State Police and local ... naloxone. Heroin and opioid overdose are the ... , killing more individuals than those involved in ... died from a drug overdose. " ...
Breaking Medicine Technology:Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3
(Date:8/31/2015)... ... August 31, 2015 , ... CareSource, a nonprofit Ohio-based health ... this capacity, Michael will provide strategic leadership for CareSource’s marketing, branding, corporate communications ... that have contributed to the company’s rapid growth. As the CareSource business model ...
(Date:8/31/2015)... Carolina (PRWEB) , ... August 31, 2015 , ... The ... Laurels on Tuesday, September 1. , “Alive Inside” shadows a social worker who ... & MEMORY?.” , “It’s a documentary about bringing music to residents in health care ...
(Date:8/31/2015)... ... August 31, 2015 , ... David L. ... was one of the first doctors in the area to perform minimally invasive ... have been impressive: faster recovery, decreased immediate and long-term pain, and an accelerated ...
(Date:8/31/2015)... ... 2015 , ... With the FCPX LUT Soft pack from Pixel Film Studios, editors can quickly ... contains a mathematical formula for modifying an image. The LUT changes every pixel's color to ... files. , FCPX LUT Soft requires Final Cut Pro X 10.2 or newer. , ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... communications company announced today that it has officially launched a new website and ... website and brand refresh are more closely aligned with the company’s strategic vision ...
Breaking Medicine News(10 mins):Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3
... can be used to measure cardiac function and has ... are limited, a preliminary study indicates. , CT coronary ... and function; however, CT coronary angiography uses a high ... nuclear medicine examinations, can evaluate structure and function with ...
... production is controlled could lead to improvements in the ... Australian medical researchers. , The findings are reported in ... American Society of Hematology and the worlds premier hematology ... Western Australian Institute for Medical Research (WAIMR) Director Peter ...
... of money, human resources, analysis concludes , , FRIDAY, ... countries most in need of improving mother and child ... meeting internationally set goals over the past three years, ... Countdown to 2015 for Maternal, Newborn and Child Survival, ...
... /Xinhua-PRNewswire-FirstCall/ -- China Medical,Technologies, Inc. (the ,Company,) ... device company that develops, manufactures and markets ... ultrasound tumor,therapy systems, today announced that it ... fourth quarter and fiscal year ended March ...
... Gen-Probe Incorporated,(Nasdaq: GPRO ) announced today that the ... Monday, April 28, 2008 at approximately,4:00 p.m. Eastern Time ... at 4:30 p.m. ET. Henry L. Nordhoff, chairman and ... and,chief financial officer, will host the call., The ...
... finds Internet searches provide more on ,how to, than ,how ... A new British study says that people surfing the Web ... that encourage the act rather than offering help and support. ... entered a dozen search terms, one at a time, into ...
Cached Medicine News:Health News:Twin findings raise hopes of improved anemia treatments 2Health News:Few Countries on Track to Curb Maternal, Child Mortality Rates 2Health News:Few Countries on Track to Curb Maternal, Child Mortality Rates 3Health News:China Medical Technologies to Announce 4QFY2007 Financial Results, Declare Annual Cash Dividend and Provide FY2008 Annual Targets on June 12, 2008 2Health News:Gen-Probe Announces Webcast of First Quarter 2008 Earnings Conference Call 2Health News:Suicide Data on Web Mostly Not Preventive 2
... a high performance temperature controlled shaker which ... speed and incubation time are fully programmable ... are displayed on the LCD in real ... the microplates provide uniform incubation with less ...
... The iEMS Incubator/Shaker HT ... Thus, the iEMS Incubator/Shaker HT ... as DNA hybridization and primer ... is available as a one-cabinet ...
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
Form: Cream-colored powder Moisture: 10% Ash: 6.5% Gel Strength (1.5%): 550 950 gm/cm 2 Gel pH (1.5%): 6.0 7.5 Gel Point (1.5%): 34 38C Melting Point (1.5%): 84 88C Application: Bacterial ...
Medicine Products: